Gastroenterology — MCQs

A 45-year-old male presents with fever, chronic diarrhea, and weight loss. He is found to have migratory polyarthritis and generalized lymphadenopathy. Physical examination reveals skin hyperpigmentation. A biopsy from his small intestines reveals the presence of macrophages in the lamina propria that contain PAS-positive cytoplasm. What is the most likely diagnosis for this individual?

Q479Easy

All of the following are seen in chronic calcific pancreatitis except?

Q480Medium

A 27-year-old man presents with chronic, itchy skin and progressive fatigue. Physical examination reveals mild jaundice, with no specific skin lesions. Serum chemistry shows elevated alkaline phosphatase and bilirubin, with minimally increased transaminases. Endoscopic retrograde cholangiography demonstrates multiple short strictures and saccular dilatations involving the intrahepatic and extrahepatic bile ducts. Which of the following is the most likely diagnosis?

Gastroenterology Indian Medical PG Practice Questions and MCQs

Question 471: A businessman diagnosed with gastroesophageal reflux disease (GERD) presents with substernal heartburn. What is the best test to diagnose GERD and quantify acid output?

A. Esophagogram
B. Endoscopy
C. Manometry
D. 24-hour pH monitoring (Correct Answer)

Explanation: **Explanation:** The diagnosis of Gastroesophageal Reflux Disease (GERD) is primarily clinical; however, when objective confirmation and quantification of acid exposure are required, **24-hour ambulatory pH monitoring** is the **Gold Standard**. It allows for the correlation of symptoms (heartburn, cough) with actual reflux episodes by measuring the percentage of time the esophageal pH remains below 4.0. **Analysis of Options:** * **24-hour pH monitoring (Correct):** It is the most sensitive and specific test to diagnose GERD and is the only modality that can **quantify** the total acid output/exposure over a day. * **Endoscopy (EGD):** While it is the first-line investigation to look for complications (like Barrett’s esophagus or esophagitis), it has low sensitivity for diagnosing GERD itself, as many patients have "Non-Erosive Reflux Disease" (NERD) where the mucosa appears normal. * **Manometry:** This is used to assess esophageal motility (e.g., Achalasia) and to locate the Lower Esophageal Sphincter (LES) before pH probe placement or anti-reflux surgery. It does not diagnose or quantify acid reflux. * **Esophagogram (Barium Swallow):** This is useful for identifying structural abnormalities like hiatal hernias, strictures, or rings, but it cannot reliably diagnose or quantify GERD. **Clinical Pearls for NEET-PG:** * **Investigation of Choice (IOC) for GERD:** 24-hour pH monitoring. * **Best Initial Investigation:** Upper GI Endoscopy (to rule out malignancy/complications). * **DeMeester Score:** A composite score used in pH monitoring to quantify the severity of reflux (Score >14.72 indicates significant GERD). * **Bravo Capsule:** A wireless pH monitoring system that is better tolerated than the transnasal catheter.

Question 472: Which of the following is not associated with Crohn's disease?

A. Fistula
B. Stricture
C. Sclerosing cholangitis
D. None (Correct Answer)

Explanation: **Explanation:** The correct answer is **None**, as all the listed options (Fistula, Stricture, and Sclerosing Cholangitis) are well-recognized associations or complications of Crohn’s Disease (CD). 1. **Fistula (Option A):** Crohn’s disease is characterized by **transmural inflammation** (involving all layers of the bowel wall). This deep inflammation leads to the formation of sinus tracts that can penetrate through the serosa into adjacent organs or the skin, resulting in entero-enteric, entero-vesical, or perianal fistulae. 2. **Stricture (Option B):** Chronic transmural inflammation leads to collagen deposition and fibrosis. Over time, this causes narrowing of the bowel lumen, resulting in fibrostenotic strictures, a hallmark feature of CD that often leads to intestinal obstruction [1]. 3. **Sclerosing Cholangitis (Option C):** Primary Sclerosing Cholangitis (PSC) is an extra-intestinal manifestation of Inflammatory Bowel Disease (IBD). While PSC is more strongly associated with Ulcerative Colitis (approx. 70-80% of PSC patients have UC), it is also significantly associated with Crohn’s disease, particularly when there is colonic involvement [1]. **NEET-PG High-Yield Pearls:** * **Transmural vs. Mucosal:** CD is transmural (leads to fistulae/strictures); UC is limited to the mucosa/submucosa (leads to pseudopolyps). * **Skip Lesions:** CD presents with "skip lesions" and a "cobblestone appearance," whereas UC involves continuous inflammation starting from the rectum. * **Granulomas:** Non-caseating granulomas are pathognomonic for CD (found in ~40-60% of cases) but are absent in UC. * **Smoking:** Smoking is a risk factor for CD but appears to be protective against UC.

Question 473: In portal hypertension, what are the sites of portosystemic anastomosis?

A. Lower end of esophagus
B. Around the umbilicus
C. Lower third of the rectum and anal canal
D. All of the above (Correct Answer)

Explanation: Explanation: Portal hypertension occurs when the pressure in the portal venous system increases, leading to the opening of collateral channels between the portal and systemic venous systems [1]. These sites of **portosystemic anastomosis** are critical clinical landmarks. **1. Lower end of esophagus (Option A):** Here, the **left gastric vein** (portal) anastomoses with the **azygos vein** (systemic). Clinically, this manifests as **esophageal varices**, which are prone to life-threatening hematemesis [1]. **2. Around the umbilicus (Option B):** The **paraumbilical veins** (portal) communicate with the **superficial epigastric veins** (systemic). Dilatation of these veins results in the classic **"Caput Medusae"** appearance [1]. **3. Lower third of the rectum and anal canal (Option C):** The **superior rectal vein** (portal) anastomoses with the **middle and inferior rectal veins** (systemic). This leads to the formation of **anorectal varices** (distinct from internal hemorrhoids) [1]. **Conclusion:** Since all three sites represent major areas where the portal and systemic circulations meet, **Option D (All of the above)** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** * **Retroperitoneal (Retzius) Site:** Anastomosis between colic veins (portal) and renal/lumbar veins (systemic) [1]. * **Bare area of the liver:** Anastomosis between hepatic portal veins and phrenic veins (systemic). * **Cruveilhier-Baumgarten Syndrome:** A clinical sign where a venous hum is heard over the epigastrium due to recanalization of the umbilical vein. * **Most common site of bleeding:** Esophageal varices.

Question 474: Which test is used to diagnose pancreatic steatorrhea?

A. Schilling test
B. Serum lipase
C. Serum amylase
D. Fecal elastase level (Correct Answer)

Explanation: ### Explanation **Correct Option: D. Fecal elastase level** Pancreatic steatorrhea occurs when the pancreas fails to produce or secrete sufficient digestive enzymes (Exocrine Pancreatic Insufficiency - EPI), leading to malabsorption of fats. **Fecal Elastase-1** is a proteolytic enzyme produced by the pancreas that remains stable during intestinal transit and is concentrated in the stool [1]. * **Mechanism:** Because it is not degraded by other enzymes, its concentration in feces directly reflects pancreatic exocrine secretory capacity [1]. * **Clinical Significance:** A level **<200 µg/g** of stool is diagnostic of EPI. It is the preferred non-invasive "gold standard" screening test due to its high sensitivity and specificity compared to other stool tests. **Why other options are incorrect:** * **A. Schilling test:** Historically used to determine the cause of Vitamin B12 deficiency (e.g., Pernicious anemia vs. malabsorption). It does not measure fat malabsorption. * **B & C. Serum Lipase and Amylase:** These are markers of **acute pancreatic inflammation** (Acute Pancreatitis). In chronic pancreatic insufficiency leading to steatorrhea, these levels are typically normal or even low due to the destruction of acinar tissue. **NEET-PG High-Yield Pearls:** * **Definition of Steatorrhea:** Excretion of **>7g of fat/day** in stool (on a 100g fat diet). * **72-hour Fecal Fat Estimation:** The definitive quantitative test for steatorrhea, but clinically cumbersome compared to fecal elastase. * **Sudan III Stain:** A rapid qualitative screening test for fecal fat. * **Secretin Stimulation Test:** The most sensitive **invasive** test for early chronic pancreatitis, but rarely performed due to its complexity. * **Clinical Rule:** Steatorrhea usually only manifests when **>90%** of pancreatic exocrine function is lost.

Question 475: A patient presents with unconjugated hyperbilirubinemia and elevated urobilinogen levels in urine. What is the most likely diagnosis?

A. Hemolytic Jaundice (Correct Answer)
B. Crigler-Najjar syndrome
C. Gilbert's syndrome
D. Dubin-Johnson syndrome

Explanation: The clinical presentation of **unconjugated hyperbilirubinemia** combined with **elevated urinary urobilinogen** is a classic hallmark of **Hemolytic Jaundice**. [1] **1. Why Hemolytic Jaundice is correct:** In hemolysis, there is an excessive breakdown of hemoglobin, leading to an overproduction of unconjugated bilirubin (UCB). The liver conjugates as much as possible and excretes it into the bile. In the intestine, this excess bilirubin is converted by bacteria into **stercobilinogen/urobilinogen**. A significant portion of this increased urobilinogen is reabsorbed into the portal circulation (enterohepatic circulation) and subsequently excreted by the kidneys, leading to high urinary urobilinogen levels. [1] Notably, urine bilirubin is absent (acholuric jaundice) because UCB is water-insoluble. **2. Why other options are incorrect:** * **Gilbert’s & Crigler-Najjar Syndromes:** These are genetic defects in the conjugation enzyme (UGT1A1). [1] While they cause unconjugated hyperbilirubinemia, the total amount of bilirubin reaching the gut is **decreased or normal**, meaning urobilinogen levels will not be elevated. * **Dubin-Johnson Syndrome:** This is a conjugated hyperbilirubinemia caused by a defect in bilirubin excretion into the bile canaliculi. [1] It would present with bilirubinuria (dark urine) rather than isolated urobilinogen elevation. **High-Yield NEET-PG Pearls:** * **Hemolysis:** ↑ UCB, ↑ Urinary Urobilinogen, **Absent** Urinary Bilirubin. [1] * **Obstructive Jaundice:** ↑ Conjugated Bilirubin, **Absent** Urinary Urobilinogen (bile doesn't reach the gut), **Present** Urinary Bilirubin. [2] * **Gilbert Syndrome:** Most common hereditary hyperbilirubinemia; jaundice is typically triggered by fasting or stress. [1] * **Dubin-Johnson:** Characterized by a **black liver** on biopsy due to melanin-like pigment.

Question 476: A patient presenting with spider telangiectatic spots on the skin should undergo examination to determine the condition of which organ?

A. Lungs
B. Liver (Correct Answer)
C. Kidneys
D. Pancreas

Explanation: **Explanation:** Spider telangiectasias (spider angiomas) are classic cutaneous markers of **chronic liver disease (CLD)**, most commonly associated with cirrhosis [1]. **Why Liver is Correct:** The primary pathophysiology involves **hyperestrogenism**. In a failing liver, there is decreased metabolism of steroid hormones and increased peripheral conversion of androgens to estrogens [1]. Elevated circulating estrogen levels cause permanent dilatation of precapillary arterioles. These lesions typically appear in the distribution of the superior vena cava (face, neck, upper chest, and arms) and exhibit "central pulsatility" with peripheral radiating capillaries that blanch upon pressure. **Why Other Options are Incorrect:** * **Lungs:** While hepatopulmonary syndrome can occur in liver patients, spider nevi are not a direct sign of primary lung pathology. * **Kidneys:** Chronic Kidney Disease (CKD) presents with skin changes like uremic frost, pruritus, or hyperpigmentation, but not spider telangiectasias [2]. * **Pancreas:** Chronic pancreatitis or pancreatic cancer may cause jaundice (if the bile duct is obstructed) or migratory thrombophlebitis (Trousseau sign), but they do not typically cause hyperestrogenism-induced vascular changes. **High-Yield Clinical Pearls for NEET-PG:** * **Number Matters:** Finding more than **five** spider angiomas is highly suggestive of liver cirrhosis [3]. * **Other Hyperestrogenic States:** They can also be seen in pregnancy and thyrotoxicosis. * **Associated Findings:** Often seen alongside other "estrogen-excess" signs like **palmar erythema** and **gynecomastia** [1]. * **Disappearance:** These lesions often disappear if liver function improves or following a liver transplant.

Question 477: Which autoantibodies are seen in type 1 autoimmune hepatitis?

A. Anti-mitochondrial antibodies
B. Anti-nuclear antibodies (Correct Answer)
C. Anti-LKM-1 antibodies
D. Anti-LKM-2 antibodies

Explanation: **Explanation:** Autoimmune Hepatitis (AIH) is a chronic inflammatory liver disease characterized by hypergammaglobulinemia and the presence of specific circulating autoantibodies. It is broadly classified into two types based on the antibody profile: * **Type 1 AIH (Classic):** This is the most common form (80% of cases) and can occur at any age. It is characterized by the presence of **Anti-nuclear antibodies (ANA)** and/or **Anti-smooth muscle antibodies (ASMA)**. * **Type 2 AIH:** This type typically affects children and adolescents. It is characterized by **Anti-liver kidney microsomal type 1 (Anti-LKM-1)** antibodies and/or Anti-liver cytosol type 1 (Anti-LC1) antibodies. **Analysis of Options:** * **Option A (Anti-mitochondrial antibodies):** These are the hallmark of **Primary Biliary Cholangitis (PBC)**, not AIH. * **Option C (Anti-LKM-1 antibodies):** These are diagnostic for **Type 2 AIH**, which is clinically more severe and often resistant to treatment compared to Type 1. * **Option D (Anti-LKM-2 antibodies):** These are associated with **drug-induced hepatitis** (specifically ticrynafen), not autoimmune hepatitis. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard Diagnosis:** Liver biopsy showing **Interface Hepatitis** (piecemeal necrosis) and plasma cell infiltration. * **Treatment:** Prednisolone (corticosteroids) alone or in combination with Azathioprine. * **Associated Conditions:** Type 1 AIH is frequently associated with other autoimmune diseases like HLA-DR3 or DR4, autoimmune thyroiditis, and Celiac disease. * **Seronegative AIH:** About 10-20% of patients may be antibody-negative at presentation.

Question 478: A 45-year-old male presents with fever, chronic diarrhea, and weight loss. He is found to have migratory polyarthritis and generalized lymphadenopathy. Physical examination reveals skin hyperpigmentation. A biopsy from his small intestines reveals the presence of macrophages in the lamina propria that contain PAS-positive cytoplasm. What is the most likely diagnosis for this individual?

A. Crohn's disease
B. Hanup disease
C. Nontropical sprue
D. Whipple's disease (Correct Answer)

Explanation: ### Explanation **Whipple’s Disease** is a rare systemic infectious disease caused by the gram-positive actinomycete **_Tropheryma whipplei_**. It typically affects middle-aged males [1]. **Why Option D is correct:** The clinical presentation in this case is classic for Whipple’s disease, often remembered by the mnemonic **"4Ms"**: **M**alabsorption (diarrhea/weight loss), **M**igratory polyarthritis (often the earliest symptom), **M**esenteric lymphadenopathy, and **M**yocardial/CNS involvement [1]. Hyperpigmentation is a common cutaneous finding [1]. The pathognomonic histological feature is the presence of **PAS-positive, diastase-resistant macrophages** in the lamina propria of the small intestine, which contain the causative bacilli (seen on electron microscopy) [1]. **Why other options are incorrect:** * **Crohn’s Disease:** While it presents with diarrhea and weight loss, the biopsy would show non-caseating granulomas and transmural inflammation, not PAS-positive macrophages. * **Hartnup Disease:** This is a metabolic disorder of tryptophan transport characterized by pellagra-like skin rashes, ataxia, and aminoaciduria, rather than chronic diarrhea and arthritis. * **Nontropical Sprue (Celiac Disease):** This presents with malabsorption but is characterized histologically by villous atrophy, crypt hyperplasia, and increased intraepithelial lymphocytes [2]. It does not cause migratory arthritis or PAS-positive macrophage infiltration. **High-Yield Pearls for NEET-PG:** * **Organism:** *Tropheryma whipplei* (Gram-positive) [1]. * **Classic Triad:** Diarrhea, Weight loss, and Arthritis [1]. * **Specific Sign:** Oculomasticatory myorhythmia (pathognomonic CNS sign). * **Treatment:** Ceftriaxone (initial) followed by oral Trimethoprim-Sulfamethoxazole (TMP-SMX) for 1 year. * **Differential:** *Mycobacterium avium-intracellulare* (MAI) also shows PAS-positive macrophages but is **Acid-Fast Bacilli (AFB) positive**, whereas *T. whipplei* is **AFB negative**.

Question 479: All of the following are seen in chronic calcific pancreatitis except?

A. Diabetes mellitus
B. Fat malabsorption
C. Hypercalcemia (Correct Answer)
D. Recurrent abdominal pain

Explanation: **Explanation:** Chronic calcific pancreatitis (CCP) is characterized by progressive, irreversible inflammation leading to the destruction of both endocrine and exocrine components of the pancreas [1]. **Why Hypercalcemia is the Correct Answer:** Hypercalcemia is a **cause**, not a consequence, of chronic pancreatitis. Elevated serum calcium levels (often due to primary hyperparathyroidism) can lead to the formation of intraductal calcium stones and the activation of trypsinogen within the pancreas, triggering inflammation. Conversely, chronic pancreatitis itself does not cause hypercalcemia; in fact, severe acute episodes can sometimes lead to *hypocalcemia* due to the saponification of fats [1]. **Analysis of Incorrect Options:** * **Diabetes Mellitus:** This is a late-stage complication. Destruction of the Islets of Langerhans leads to "pancreatogenic diabetes" (Type 3c DM), characterized by a loss of both insulin and glucagon. * **Fat Malabsorption:** Exocrine insufficiency occurs when >90% of the pancreatic function is lost. This results in steatorrhea (foul-smelling, oily stools) because the pancreas fails to secrete adequate lipase [1]. * **Recurrent Abdominal Pain:** This is the most common presenting symptom [1]. The pain is typically epigastric, radiates to the back, and is caused by increased intrapancreatic pressure and neural inflammation [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Classic Triad:** Pancreatic calcification (most specific), steatorrhea, and diabetes mellitus. * **Most Common Cause:** Alcohol abuse (Western world); Tropical pancreatitis (common in parts of India) [1]. * **Imaging:** CT scan is the gold standard for detecting calcifications [2]. * **Management:** Enzyme replacement (Creon) for malabsorption and "step-up" analgesia for pain.

Question 480: A 27-year-old man presents with chronic, itchy skin and progressive fatigue. Physical examination reveals mild jaundice, with no specific skin lesions. Serum chemistry shows elevated alkaline phosphatase and bilirubin, with minimally increased transaminases. Endoscopic retrograde cholangiography demonstrates multiple short strictures and saccular dilatations involving the intrahepatic and extrahepatic bile ducts. Which of the following is the most likely diagnosis?

A. Ascending cholangitis
B. Bile duct tumor
C. Primary biliary sclerosis
D. Primary sclerosing cholangitis (Correct Answer)

Explanation: ### **Explanation** The clinical presentation and imaging findings are classic for **Primary Sclerosing Cholangitis (PSC)** [3]. **1. Why Option D is Correct:** PSC is a chronic cholestatic liver disease characterized by inflammation and obliterative fibrosis of the bile ducts [2]. * **Clinical Presentation:** It typically affects young to middle-aged men (often associated with Ulcerative Colitis) [2]. Symptoms include fatigue, pruritus (itchy skin), and jaundice [1], [3]. * **Biochemical Profile:** A **cholestatic pattern** is seen, with significantly elevated Alkaline Phosphatase (ALP) and bilirubin, but only mild elevations in ALT/AST [3]. * **Imaging (Gold Standard):** Endoscopic Retrograde Cholangiopancreatography (ERCP) or MRCP reveals the pathognomonic **"beaded appearance"**—multifocal short strictures alternating with normal or dilated segments (saccular dilatations) involving both intrahepatic and extrahepatic ducts. **2. Why Other Options are Incorrect:** * **A. Ascending Cholangitis:** This is an acute bacterial infection presenting with **Charcot’s Triad** (fever, jaundice, RUQ pain). It is an acute emergency, not a chronic condition. * **B. Bile Duct Tumor (Cholangiocarcinoma):** While PSC is a risk factor for this, a tumor usually presents as a single, high-grade focal obstruction rather than diffuse "beading" across the entire biliary tree. * **C. Primary Biliary Sclerosis (Primary Biliary Cholangitis - PBC):** PBC primarily affects middle-aged **women** and involves only the **small intrahepatic ducts** [2]. Crucially, the ERCP/MRCP in PBC is typically **normal**, and it is diagnosed via Anti-Mitochondrial Antibodies (AMA) [2]. **3. High-Yield Clinical Pearls for NEET-PG:** * **Association:** ~70-80% of PSC patients have **Inflammatory Bowel Disease (IBD)**, most commonly Ulcerative Colitis [2], [3]. * **Antibody:** **p-ANCA** is often positive in PSC (though not specific) [2], [3]. * **Histology:** May show **"onion-skin" fibrosis** (periductal fibrosis), though biopsy is often unnecessary if imaging is diagnostic. * **Complication:** Increased risk of **Cholangiocarcinoma** and Colorectal Cancer. * **Treatment:** Liver transplantation is the only definitive treatment for end-stage disease.

Practice by Chapter

Esophageal Disorders

Practice Questions

Peptic Ulcer Disease

Practice Questions

Inflammatory Bowel Disease

Practice Questions

Irritable Bowel Syndrome

Practice Questions

Malabsorption Syndromes

Practice Questions

Pancreatitis (Acute and Chronic)

Practice Questions

Gastrointestinal Bleeding

Practice Questions

Liver Diseases and Cirrhosis

Practice Questions

Viral Hepatitis

Practice Questions

Biliary Tract Disorders

Practice Questions

Gastrointestinal Motility Disorders

Practice Questions

Gastrointestinal Malignancies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free